Victory Capital Holdings heads into today's earnings print as one of the clearest cases of price running well ahead of analyst conviction.
The stock has climbed 31% over the past month to $82.29, yet the Street's consensus target sits at $74.80 — meaning the market has already priced through what most analysts think the stock is worth. Options traders are not hedging that gap. The put/call ratio is exceptionally low at 0.21, roughly half its 20-day average of 0.41, and well below its 52-week midpoint. That is not a cautious crowd — it reflects dominant call positioning, consistent with investors leaning into the move rather than protecting against a reversal.
The short side is not pushing back hard. Short interest runs at 4.7% of the free float, up about 10% over the past month as the stock rallied, but the borrow market shows no real stress. Cost to borrow is just 0.50% annually — effectively free. Availability is loose, with utilisation at only 18.7%, far below its 52-week peak of 37%. Shorts have been adding incrementally but have no leverage to force a squeeze narrative, and no squeeze pressure from the lending market either.
Where analysts diverge is on whether the recent re-rating is earned. JP Morgan and Barclays both nudged targets higher in April — to $72 and $74 respectively — while maintaining neutral-equivalent ratings. Neither moved their stance despite the rally. RBC is the lone outperformer in the group, with a target of $84 that now sits just above the current price. The P/E multiple has expanded roughly 2.6 points over 30 days to nearly 11.7x, and the P/B has risen 0.6x to 2.7x in the same window — a meaningful re-rating for an asset manager. On the forward earnings side, the 12-month EPS growth estimate ranks in the 92nd percentile of the universe, which gives bulls a fundamental anchor for the move. The dividend score ranks in the 98th percentile, adding an income angle that supports the valuation argument.
One thread worth noting on ownership: CEO David Brown and CFO Michael Policarpo both sold in March at $66.67 — well below today's price — alongside the CLO and a divisional president. The cluster sale was part of what appears to be an annual March programme, with similar transactions in March 2025 and 2024, so the pattern looks routine rather than a signal. Still, at $82, the stock is 23% above the price at which the CEO last sold shares.
The print will test whether AUM flows and fee revenue can justify a valuation that the Street's consensus already considers stretched.
See the live data behind this article on ORTEX.
Open VCTR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
